Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Jen Hong

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Haematology|September 6, 2014
Hereditary erythrocytosis, thrombocytosis and neutrophiliaWan-Jen Hong, Jason Gotlib
Expert Review of Hematology|April 19, 2011
Unfavorable-risk cytogenetics in acute myeloid leukemiaWan-Jen Hong, Bruno C Medeiros
Nucleic Acids Research|October 15, 2009
Local false discovery rate facilitates comparison of different microarray experimentsWan-Jen Hong, Robert Tibshirani, Gilbert Chu
Plos One|March 25, 2014
Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasmsJoanna Y Lee, Wan-Jen Hong, Ravindra Majeti, et al.
Cancer Medicine|August 17, 2021
Front-line treatment patterns in multiple myeloma: An analysis of U.S.-based electronic health records from 2011 to 2019Shaji Kumar, Mellissa Williamson, Uzor Ogbu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remissionM Ryan Corces-Zimmerman, Wan-Jen Hong, Irving L Weissman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damageKerri E Rieger, Wan-Jen Hong, Virginia Goss Tusher, et al.
Nature Medicine|May 24, 2016
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cellsAndreas Reinisch, Daniel Thomas, M Ryan Corces, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple MyelomaNathaniel J Myall, Samantha X Wang, Evan T Hall, et al.
Blood Cancer Journal|March 24, 2022
Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysisShebli Atrash, Evelyn M Flahavan, Tao Xu, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Haematology|September 6, 2014
Hereditary erythrocytosis, thrombocytosis and neutrophiliaWan-Jen Hong, Jason Gotlib
Expert Review of Hematology|April 19, 2011
Unfavorable-risk cytogenetics in acute myeloid leukemiaWan-Jen Hong, Bruno C Medeiros
Nucleic Acids Research|October 15, 2009
Local false discovery rate facilitates comparison of different microarray experimentsWan-Jen Hong, Robert Tibshirani, Gilbert Chu
Plos One|March 25, 2014
Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasmsJoanna Y Lee, Wan-Jen Hong, Ravindra Majeti, et al.
Cancer Medicine|August 17, 2021
Front-line treatment patterns in multiple myeloma: An analysis of U.S.-based electronic health records from 2011 to 2019Shaji Kumar, Mellissa Williamson, Uzor Ogbu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remissionM Ryan Corces-Zimmerman, Wan-Jen Hong, Irving L Weissman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damageKerri E Rieger, Wan-Jen Hong, Virginia Goss Tusher, et al.
Nature Medicine|May 24, 2016
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cellsAndreas Reinisch, Daniel Thomas, M Ryan Corces, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple MyelomaNathaniel J Myall, Samantha X Wang, Evan T Hall, et al.
Blood Cancer Journal|March 24, 2022
Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysisShebli Atrash, Evelyn M Flahavan, Tao Xu, et al.
Pageof 3